Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Mato

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 28, 2022
Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentaryAnthony Mato
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Clinical Lymphoma, Myeloma & Leukemia|April 25, 2018
Immunotherapy for the Treatment of Hodgkin Lymphoma: An Evolving ParadigmSteven M Bair, Anthony Mato, Jakub Svoboda
Cancer|March 19, 2008
Valproic acid for the treatment of myeloid malignanciesPayal Shah, Anthony Mato, Selina M Luger
American Journal of Hematology|March 27, 2015
Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitorsAnthony Mato, Shekeab Jauhari, Stephen J Schuster
Current Oncology Reports|April 13, 2018
Monitoring and Management of Toxicities of Novel B Cell Signaling AgentsJoanna Rhodes, Anthony Mato, Jeff P Sharman
JAMA Oncology|July 28, 2017
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A ReviewMeghan Thompson, Danielle Brander, Chadi Nabhan, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
Clinics in Geriatric Medicine|February 14, 2012
Liquid tumors in the elderlyAnthony Mato, Tatyana Feldman, Joshua Richter, et al.
Cancer Biology & Therapy|January 6, 2007
Spontaneous tumor lysis syndrome in acute myeloid leukemia: two cases and a review of the literatureBrett Riccio, Anthony Mato, Erin M Olson, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Advances in Hematology & Oncology : H&O|March 28, 2022
Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentaryAnthony Mato
Blood|June 13, 2015
A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARsAnthony Mato, David L Porter
Clinical Lymphoma, Myeloma & Leukemia|April 25, 2018
Immunotherapy for the Treatment of Hodgkin Lymphoma: An Evolving ParadigmSteven M Bair, Anthony Mato, Jakub Svoboda
Cancer|March 19, 2008
Valproic acid for the treatment of myeloid malignanciesPayal Shah, Anthony Mato, Selina M Luger
American Journal of Hematology|March 27, 2015
Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitorsAnthony Mato, Shekeab Jauhari, Stephen J Schuster
Current Oncology Reports|April 13, 2018
Monitoring and Management of Toxicities of Novel B Cell Signaling AgentsJoanna Rhodes, Anthony Mato, Jeff P Sharman
JAMA Oncology|July 28, 2017
Minimal Residual Disease in Chronic Lymphocytic Leukemia in the Era of Novel Agents: A ReviewMeghan Thompson, Danielle Brander, Chadi Nabhan, et al.
American Journal of Hematology|August 29, 2007
Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin levelDonald E Tsai, Anthony Mato, David L Porter, et al.
Clinics in Geriatric Medicine|February 14, 2012
Liquid tumors in the elderlyAnthony Mato, Tatyana Feldman, Joshua Richter, et al.
Cancer Biology & Therapy|January 6, 2007
Spontaneous tumor lysis syndrome in acute myeloid leukemia: two cases and a review of the literatureBrett Riccio, Anthony Mato, Erin M Olson, et al.
Pageof 7